Bayer Essure Inc., a subsidiary of Bayer AG, is a prominent player in the healthcare industry, headquartered in the United States. Founded in the early 2000s, the company has made significant strides in women's health, particularly in the field of permanent contraception. Essure, its flagship product, is a non-surgical, hysteroscopic sterilisation device that offers a unique alternative to traditional surgical methods. With a focus on innovation, Bayer Essure has positioned itself as a leader in the contraceptive market, providing women with a safe and effective option for family planning. The company has achieved notable milestones, including extensive clinical studies that underscore the efficacy and safety of its products. As a trusted name in women's health, Bayer Essure continues to advance its mission of empowering women through informed reproductive choices.
How does Bayer Essure Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bayer Essure Inc.'s score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bayer Essure Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Bayer Aktiengesellschaft, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Bayer Essure Inc., it is important to note that any climate initiatives or targets would likely be inherited from its parent company, Bayer Aktiengesellschaft. This includes potential commitments to the Science Based Targets initiative (SBTi) and other climate-related frameworks, which are cascaded down from Bayer Aktiengesellschaft. As a subsidiary, Bayer Essure Inc. may align its sustainability efforts with the broader goals set by Bayer Aktiengesellschaft, which is actively engaged in reducing its carbon footprint and addressing climate change. However, without specific data or targets from Bayer Essure Inc. itself, the details of its individual climate commitments remain unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Bayer Essure Inc.'s Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bayer Essure Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.